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Abstract 
 
 
 
 
Identification of molecules in complex mixtures is a fundamental problem in analytical 
chemistry. NMR is widely used for molecular identification in impure samples, but traditionally 
is an expensive technique that requires a large-scale laboratory setting and extensive training to 
operate. New relaxometric techniques have been developed for low-cost NMR apparatuses with 
strong field inhomogeneities, where change in relaxation time T2 of water surrounding the 
aggregation of paramagnetic nanoparticles around a given analyte is measured. These devices’ 
strong magnetic field gradients make them suitable for simultaneous measurement of the self-
diffusion constant D. In this study, the advantages of a two-dimensional T2-D approach to 
molecular identification of a protein-specific ligand analyte in complex with its target protein are 
assessed as a “proof of principle” experiment. Since complexation reduces molecular motion, we 
expect both T2 and D will decrease, indicating the presence of the ligand by the shape and size of 
the sensor as a unit rather than its chemical makeup. Per the complex nature of our selected 
protein-ligand binding interactions (those of bovine serum albumin and naproxen), the detection 
of a number of unexpected phenomena, including naproxen self-association, non-specific 
binding interactions, and possibly rapid chemical exchange are reported. A potential method by 
which low-field, single-sided NMR devices may be used to determine thermodynamic constants 
is also demonstrated. 
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1 Introduction 
1.1 Supplemental Background of NMR Spectroscopy 
This study sought to assess as a proof-of-principle experiment the advantages and 
disadvantages of a so-called “low-field” Nuclear Magnetic Resonance (NMR) approach to 
molecular identification. Thus, a brief description of the principles of NMR before going into 
detail about the research performed is appropriate. When relevant, more conventional, “high-
field” techniques will be brought in for comparison, but otherwise this explanation will only 
cover topics necessary to understand this particular study. Further information on the subject is 
widely available thanks to authors such as Keeler,
1
 Blümich,
2
 and Cavanagh,
3
 whose work is 
recommended should the reader wish to know more. 
Currently, NMR spectroscopy is one of the predominant techniques used to determine the 
three-dimensional structures of molecules at atomic resolution.
3
 In addition, NMR is a powerful 
technique for investigating time-dependent phenomena, including reaction kinetics and 
intramolecular dynamics. Nuclear magnetic resonances in bulk condensed phase were first 
reported in 1946 by Bloch et al.
4
 and by Purcell et al.
5
. Nuclear magnetism relies upon the notion 
that all nuclei possess the quantum mechanical intrinsic properties of nuclear spin and spin 
angular momentum.
6
 Most nuclei of interest in NMR techniques possess a spin angular 
momentum quantum number (I) of 
1
2
; these include elements such as 
1
H, 
13
C, 
19
F, and 
129
Xe.
6,7
 In 
this research, only protons (
1
H) were analyzed, while other elements and isotopes (such as 
deuterium, known as either 
2
H or D) are said to be NMR inactive. This is a good assumption in 
grossly inhomogeneous fields such as the one employed by our instrument—the detection coil is 
tuned specifically to the proton frequency, a range where 
1
H is the only nucleus that produces a 
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reasonably large signal (the precise meaning of these specifications will be made more clear 
shortly). 
Associated with angular momentum is always a nuclear spin magnetic moment—in 
effect, each proton generates a small magnetic field.
1
 In NMR techniques, this field interacts 
with an applied field (B0) such that the spin falls into one of two energy states, either aligned 
with the field (lower in energy) or aligned against the field (greater in energy) . To simplify the 
true quantum mechanical environment (beyond the scope of this research), this interaction is 
further explained using a vector model: we say that the result of the interaction between 
individual magnetic moments and B0 is a summed equilibrium magnetization vector that, at 
equilibrium, is parallel to B0, where the energy of the interaction depends upon the angle 
between the two, and is lowest (most stable) when the magnetic moment is parallel to the applied 
field (θ = 0).  This vector can be visualized in a three-dimensional coordinate system running 
along the positive z-axis (as can B0). If, by some means, this magnetization vector is tipped away 
from its preferred orientation, however, it will rotate about the z-axis in a kind of motion known 
as Larmor precession (Fig. 1). In an applied magnetic field B0 the vector will precess at a 
constant frequency (ω) described by: 
𝜔 = −𝛾𝐵0 
where γ is the gyromagnetic ratio, a constant unique to each nucleus. For 1H, γ = 42.58 MHz·T-1 
or 2.675×10
8
 rad·s
-1
·T
-1
.
6
 The frequency of precession of the magnetization vector is what is 
actually detected in an NMR experiment.
1
 Typically, a small coil of wire placed around or 
underneath the sample detects precession in the form of an induced current (known as free 
induction decay, or FID) brought about as the spinning magnetization vector “cuts” across the 
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coil. The precise nature of the magnet supplying the applied field and of the coil varies with the 
specific NMR technique used; our apparatus will be discussed in more detail in the following 
section. 
 The induction of Larmor precession is where the concept of resonance comes into play in 
NMR techniques—radiofrequency (RF) power is supplied through this same coil, applying to the 
sample a small magnetic field perpendicular to B0 that oscillates at or near the Larmor precession 
frequency in the x direction. Because the oscillating field is resonant with the precession 
frequency, the magnetization vector can be tipped from its equilibrium orientation towards or 
into the transverse (x-y) plane even in the presence of a much stronger applied field B0. This 
pulse of RF power is called an on-resonance pulse, or alternatively a 90° (
𝜋
2
) pulse, and is all 
that is required for the simplest NMR process: the pulse-acquire experiment. Here, the pulse 
sequence (Fig. 3) consists only of a 90° pulse to induce Larmor precession in the relevant nuclei, 
followed by a period during which the coil is used to detect the precession’s FID. 
1.2 Single-Sided NMR 
NMR devices using lower applied field strengths (e.g. 0.5 T, vs. a high-field value of    
20 T) have been employed as easy-access, mobile, and/or low-cost analytical tools in areas of 
study where more advanced apparatuses are inconvenient or unusable.
8
 Our device, the NMR-
MOUSE, is a single-sided apparatus that uses permanent magnets to produce the applied field B0. 
Their configuration and resulting magnetic field is described in Fig. 4. More can be learned 
about the origins and construction of the NMR-MOUSE from the work of Blümich et al in 
1996.
9
 Our specific device is a newer model with some modifications compared to the original; 
relevant points about the instrument will be covered later. Being single-sided, a wide range of 
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materials can be analyzed with the MOUSE; however, this configuration results in severe 
magnetic field inhomogeneity, as well as a sharp field gradient (G). More advanced phenomena 
often measured in high-field techniques, such as chemical shift or J-coupling, cannot be easily 
measured in inhomogeneous fields. Furthermore, hardware limitations brought about by the 
single-sided design dictate some modifications to our pulse sequence beyond the simple pulse-
acquire experiment: there is a “dead time” period* after the initial 90° pulse where residual RF 
energy has yet to leave the coil, such that the MOUSE does not have time to measure 
precessional signal and frequency via FID before the signal has decayed (before the 
magnetization vector has returned to equilibrium). Previous work, known today as Hahn echoes
10
 
and the Carr-Purcell-Meiboom-Gill (CPMG) sequence,
11,12
 build off the pulse-acquire pulse 
sequence to circumvent this shortcoming of low-field NMR. Hahn echoes, so-named due to their 
discovery by E. L. Hahn in 1950, are echoes of the original FID signal created by a refocusing 
pulse of magnetization (known as a 180° or π pulse). This 180° pulse is produced by the RF coil 
a certain time after the initial 90° pulse, and flips the bulk magnetization vector along the x- or  
y-axis (depending upon the phase of the initial pulse) (Fig. 5).
10
 Recalling that the summed 
magnetization vector describes the overall trend of individual 
1
H magnetic moments, it follows 
that there will be a reconvergence of the magnetization vector back upon the original 
precessional event: each individual magnetic moment, which after the on-resonance pulse has 
returned to some unspecified orientation resulting in a summed precessional signal decay, now 
reverses direction in response to the refocusing pulse. Each individual magnetic moment 
therefore converges back on its precessional orientation (Fig. 6), with full convergence occurring 
after a measure of time equal to the delay between the 90° and 180° pulses. Since the delay time 
                                                          
*
 Though there is a dead time associated with high-field techniques as well, it is much shorter, and the 
signal persists for much longer. 
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between each magnetic pulse can be chosen at will, this precessional “echo” can be made to 
appear long after the “dead time” of both pulses, and so the echo can be detected by means of the 
RF coil.  This method allows for us to measure the original FID signal amplitude via the Hahn 
echoes; however, the FID frequency cannot be determined. 
Hahn echoes were later employed and improved upon after their discovery to access 
more information about a sample by two successive pairs of scientists: Carr and Purcell in 
1954,
11
 followed by Meiboom and Gill in 1958.
12
 Together, their work culminated in a pulse 
sequence that came to be known as the CPMG sequence. Their innovation, in short, was to 
repeat the refocusing pulse many times, alternating its phasing with respect to the 90° pulse each 
time, in order to repeatedly create Hahn echoes (Fig. 7). These echoes are themselves subject to 
decay (recall, only a single on-resonance pulse is actually applied in each iteration of the pulse 
sequence) due to several different phenomena, which are consistent and quantifiable for a given 
proton source. It is these phenomena around which this research project is designed, namely two 
properties known as T2 (transverse) relaxation and self-diffusion (D). T1 (longitudinal) relaxation 
is also used in some cases to help determine our required acquisition parameters. 
1.3 The Physical Origins of T1, T2, and D 
T1 Relaxation 
Both T1 and T2 refer to relaxometric properties—that is, processes by which the bulk 
magnetization returns to its equilibrium position. A detailed description of T1 is not necessary to 
understand the current research; it is satisfactory to understand that it is a measure of the length 
of time it takes for the energy put into a system to dissipate
1
. Signal loss due to T1 relaxation 
follows an exponential decay. Its use in our experiments was to help determine the proper 
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acquisition parameters for T2 and T2-D tests which are covered in the Experimental Methods 
section. The textbook on single-sided NMR by Blümich et al.
13
 is a suitable resource for any 
further questions the reader may have on the subject. 
T2 Relaxation 
T2 is a term for the characteristic time after which transverse magnetization decays away 
to its equilibrium value of zero, also known as transverse relaxation.
1,†
 Understanding transverse 
relaxation requires considering the given sample as a collection of many individual protons 
(within molecules) with their own magnetic moments, which then can be summed to produce a 
bulk magnetization vector. In inhomogeneous fields, each magnetic moment in fact experiences 
a slightly different magnetic environment. Application of a 90° pulse, as discussed previously, 
will shift the magnetization vectors into the transverse plane, but, due to field inhomogeneity, 
each individual magnetic moment will precess within this plane about the z-axis at a slightly 
different precessional frequency. This dephasing of precessional frequencies increases over time 
as individual magnetization vectors become more and more out of sync with each other; 
consequently, the summed bulk magnetization vector’s x-y components will decrease as those of 
the individual magnetization vectors cancel each other out. The result is the eventual decay of the 
FID signal amplitude at a rate specific to the proton source. This rate (occasionally referred to as 
R2) is often described by its reciprocal, T2. In low-field techniques, T2 can be found using CPMG 
experiments. The equation used to find T2 in this case reads thus: 
𝑆
𝑆0
= 𝑒
−𝑡 𝑇2⁄   ;  ln (
𝑆
𝑆0
) = (
−1
𝑇2
) 𝑡 
                                                          
† T2 is the inverse of R2, the rate of relaxation; thus, while T2 (having units of s) is not technically a rate, it 
still characterizes how quickly transverse relaxation occurs. 
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where S is the measured signal intensity, S0 is the greatest signal intensity measured overall 
(which is used to normalize the data), and t is the time as each CPMG-sequence scan takes place. 
By taking the natural log of both sides of the initial equation, it can be easily demonstrated that 
the natural log of the normalized signal intensity decays over time at a rate equal to −1 𝑇2⁄ . A 
plot of this log value vs. time can therefore be generated in a CMPG NMR experiment in order 
to determine T2 for the given proton source. 
D - The Self-Diffusion Coefficient 
Signal decay due to diffusion is a result of the field gradient of our single-sided NMR 
device’s applied magnetic field creating a non-ideal environment for the application of 
refocusing 180° pulses during CPMGs. Under ideal circumstances where B0 is constant 
throughout a sample, 180° pulses reflect individual magnetization vectors along the x-axis, 
which then form an echo of the original FID (as explained above). With a sharp field gradient, 
however, B0 is weaker at greater heights above our apparatus’ sensing surface, and different 
depths of a given sample experience different magnetic field strengths (Fig. 8). As a result of 
molecular motion, then, protons will experience different field strengths as they move about 
within the sample, and thus will precess at different frequencies at one time during an experiment 
compared to another. In such conditions, upon application of a refocusing pulse during CPMG, a 
given proton magnetic moment will reverse direction and converge back on its initial FID 
orientation at a different rate from the one it experienced previously. Each magnetic moment will 
therefore no longer converge directly back on its original orientation, resulting in a reduction in 
intensity of the echo (Fig. 9). This diffusion decay increases over time as additional refocusing 
pulses are applied. 
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In order to measure diffusion, the regular CPMG pulse sequence is modified in the 
following way: a second 90° pulse is applied after the first, after a delay time δ, which rotates the 
bulk magnetization vector out of the transverse plane; this ensures that no signal decay will occur 
due to T2 relaxation during a second delay time Δ; finally, a third 90° pulse is applied, which 
sums with the second to effectively act together as a 180° pulse, resulting in the production of a 
Hahn echo after an additional time δ (Fig. 10). This process combines well with measuring T2, 
since this echo can then be reformed as in a regular CPMG experiment using additional 
refocusing pulses. The combined pulse sequence is therefore used in multidimensional T2-D 
experiments, where both transverse relaxation and self-diffusion are measured. In ideal 
situations, where δ « T2 and Δ « T1, the equation used to find D appears thus: 
ln (
𝑆
𝑆0
) ≈ −𝛾2𝐺2𝛿2 (∆ +
2
3
𝛿) 𝐷 
where ln (
𝑆
𝑆0
) is the normalized signal intensity, γ is the gyromagnetic ratio, G is the magnetic 
field gradient of B0. As we did before for T2, the normalized signal intensity can be plotted out, 
this time vs.𝛾2𝐺2𝛿2 (∆ +
2
3
𝛿), to give a function with slope –D.  
1.4 Rationale for Exploring a Low-Field, T2-D Approach 
 As a reference, raw data of a typical T2-D experiment, showing signal decay due both to 
T2 and D vs. time (specifically, acquisition time for T2 and change in δ delay time for D) in 
depicted in Figure 11. Low-field NMR instruments must compensate for their poor signal-to-
noise ratio by repeating a given pulse sequence many times, summing each iteration or “scan” 
together to ensure representative data is collected. In the case of T2-D experiments, the delay 
time δ is then changed after a certain number of scans (each set of scans of a certain δ is called 
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an increment), providing a means to determine both T2 and D according to the equations listed 
above. 
 Multidimensional experiments are useful in molecular identification; increasing the 
number of dimensions to characterize a given sample reduces the chance of signal crowding, 
making determination of the contents more exact. T2 and D in particular are quite compatible in 
multidimensional experiments with low-field NMR. Relaxometric techniques do not require a 
homogeneous field, and thus can effectively be measured by low-field NMR devices. 
Meanwhile, our single-sided magnet’s high field gradient in fact improves the accuracy of 
measuring self-diffusion. Furthermore, as stated previously, a combined experiment is 
convenient, since a composite pulse sequence can be used that acquires the data required to 
determine both terms. At a more in-depth, conceptual level, however, they share an additional 
connection: both T2 relaxation and diffusion are related to molecular motion, and thus are related 
to molecular size. As sample proton sources get larger, they should diffuse more slowly, and 
relax more quickly (both T2 and D should therefore decrease as the size increases).  
 This last point provides a theoretical means to use low-field, single-sided NMR as a tool 
to monitor changes in molecular size as a reporter for changes in structure during chemical 
events: Molecular identification can be carried out in impure samples if an 
1
H-containing analyte 
of interest is known to bind to some other molecule of non-comparable size with high specificity. 
In a typical instance of this technique involving a comparatively small analyte and a much larger 
“probe” ligand, a T2-D experiment could be run on two samples: a control sample containing the 
original impure mixture, and a test sample into which the ligand is added to the original mixture. 
Complexation between the analyte and ligand will occur in the test sample if the analyte is 
present, causing the analyte to relax and self-diffuse along with the ligand.  A corresponding 
10 
 
drop in T2 and D for one proton source found in the control experiment can be understood to 
indicate the presence of the analyte in question in the impure sample (Fig. 12). Previous studies 
by Weissleder et al.
14,15
 have relied on a similar principle, using paramagnetic nanoparticles as 
magnetic relaxation switches. This experiment seeks in part to improve upon this body of 
work—which relied on single-dimension T2 analyses—by factoring in D to create a more 
reliable, multidimensional experiment. 
1.5 Bovine Serum Albumin & Naproxen as Test Compounds  
This technique, in analyzing molecular shape and size rather than chemical makeup, lends 
itself to a wide range of binding pairs—most readily, perhaps, protein-ligand pairs and other 
biomolecules. Many protein-ligand pairs are widely available for purchase and are incredibly 
common as test compounds in scientific research (e.g. avidin
16
 & biotin
17
). Bovine serum 
albumin (BSA) and naproxen-sodium were chosen as a test pair for our proof-of-concept 
experiment (Fig. 13). Both BSA and naproxen-sodium are relatively cheap and easy to 
acquire,
18,19
 and their interactions are well-characterized (in terms of binding interactions, 
naproxen-sodium should be entirely analogous to naproxen).
20,21
 Both compounds lend 
themselves well to analysis in the aqueous (D2O), neutral pH, room temperature environment of 
the test samples as they were originally envisioned. Important chemical properties of the two 
molecules are listed in Table 1. 
BSA monomers each possess a single binding sites for naproxen-sodium with                     
KD = 3.27×10
-8
 M.
21
 An explanation of the binding calculations used to make our test samples is 
provided in Appendix E. Additionally, it turns out that at high concentration individual BSA 
molecules dimerize (KD = 10
-5
 M).
22
 This, as we will see, results in a splitting of the BSA T2-D 
11 
 
signal into a monomer source and a dimer source. BSA dimerization was not observed to have 
any effect on the binding affinity of naproxen-sodium. 
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2  Experimental Methods 
2.1 General Protocol for Collecting T2-D Results 
 A general description of the entire protocol for producing results from a single T2-D 
experiment as a reference is provided below, before going into detail about each individual 
portion of our experimental process: 
1. The test sample is prepared. 
  
2. The NMR-MOUSE, spectrometer, power source, and computer set to acquire data are all 
turned on; the operating/processing program Prospa is loaded up on the computer in order 
to operate the magnet. A cable runs from a port on one side of the magnet housing to the 
“Probe” input port on the spectrometer.  
 
3. With no sample in place, the frequency of the magnetic field B0 is confirmed to be correct 
(it should be 19.44 MHz) using a test known as the Wobble check (all tests are selected 
from the NMR-MOUSE drop-down menu). The “Save Data” box is unchecked and the 
test is started by clicking “Run”. Generally, there should be no reason for the frequency 
to be incorrect, unless the magnet has not been plugged into the spectrometer. Once the 
frequency is confirmed, the test is ended by clicking “Abort”. 
 
4. With no sample in place, the signal-to-noise ratio is checked using the MonitorNoise test, 
and is confirmed to be acceptably low for running experiments (generally, the acceptable 
range is below 0.65). Again, this test need not be saved, and is stopped and started in the 
same way as the Wobble. 
 
5. A deionized (DI) water sample (prepared earlier and left at the instrument workstation for 
repeated use) is then placed on the magnet for use in the Calibration or “Cal” test, which 
determines the current optimum pulse length τ (in μs) by taking a determined number of 
measurements with a set of incrementally larger pulse lengths (the start, end, and 
increment size of these τ are all defined by the user). The calibration need not be saved, 
but must run to completion after clicking “Run”; the calibration cannot be aborted ahead 
of time. The relative amount of signal acquired using each possible pulse length is shown 
in a graph in the Prospa window, with both real data and noise displayed. The optimum τ 
is that which shows the largest difference between signal and noise. 
 
6. The test sample is then placed on the magnet and is run through a T1 Saturation Recovery 
(T1Sat) test in order to determine T1 (in ms). The save data box is left checked and the 
correct directory is chosen for the test files’ location, including the test’s name (T1) and 
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experiment number. This will create a folder in the given directory labeled T1 containing 
subfolders for each iteration of the test performed. 
 
7. The test sample is then run through a CPMG test to determine T2 (in ms). The data is 
saved in the same manner as the T1 test, but under the name “T2”. 
 
8. At this point, the values for T1 and T2 are entered into an excel spreadsheet designed to 
help determine the optimum acquisition parameters for a T2-D experiment, in particular 
the delay times δ and Δ (here, ms), the number of echoes, the number of scans, the 
repetition time (ms), and the number of increments—these all determine the length of 
time an experiment will take. 
 
9. A T2-D experiment is then run on the sample (referred to in Prospa as an SSE-T2 test). 
This is saved into the desired directory under the name “T2_D”. 
 
10. At the conclusion of the experiment, the raw data is accessed (for us, this was on a 
second, more powerful computer) and copied to the desktop to avoid accidental 
modification of the original files; the data consist mainly of an acqu.par file, which 
records the acquisition parameters, and three files each containing either real 
(data2d_Re.2d), imaginary (data2d_Im.2d), or complex (data2d_Cp.2d) data from the 
experiment. Prospa is again opened. From here, complex data can be dragged into a 2D 
plot window in Prospa to be processed. 
 
11. In Prospa, the raw data is prepared in order to be run through Inverse-Laplace 
transformations, which give the final T2-D distribution data used to determine results. To 
prepare, the data’s axes are defined using the Calibrate2d macro; the y-axis (change in 
delay time δ in μs) is mapped to a log scale using the Mapping function; and finally the 
data is autophased by means of the macro Phase2d. 
 
12. Once prepared thus, “Analyze2DPlotTest” is selected from the NNLS drop-down menu 
to perform the inversion. A FISTA format is used. The delay value Δ (in μs) and the time 
units used in the calibration mentioned in the previous step (again μs) are input. The 
inversion calculations are performed by selecting boundaries for the desired viewing 
range of the T2-D distribution, along with inputting the desired image resolution, or steps 
(generally, 100x100 was used in preliminary measurements; 750x750 was used for 
displaying final data). Upon clicking “Calculate” in this window, the inversion process 
will begin, taking several seconds to several minutes, depending upon the number of 
steps. For 750x750 data, the calculations took about 20 minutes to complete. 
 
13. The data should now be displayed as a T2-D distribution. Options in the “View” and 
“Calculations” drop-down menus provide the ability to either display the coordinates of 
specific points, or measure by integration what amount of total signal intensity displayed 
is contained within a box of the user’s selection. For each experiment, the T2 and D 
values for the point of highest intensity within each signal source were selected by eye, as 
14 
 
well as the peak’s signal fraction. The inverted data was then saved to our lab group’s    
Z: Drive. 
 
14. The saved inverted data was reopened in another 2D Plot window in Prospa, so that it 
could be saved again as an image (.png file). 
 
15. MATLAB is used to measure the precise point of greatest intensity for each peak (by-eye 
measurements are quick and are used to identify basic trends in the data to help guide 
further decisions), as well as calculate error boundaries by creating a contour where the 
signal intensity was 90% of the corresponding peak intensity. 
 
16. Lastly, each sample is analyzed by UV/Vis Spectroscopy in order to confirm the 
concentration of each analyte.  
2.2 Preparation of Test Samples 
 BSA and naproxen-sodium were both obtained from Sigma-Aldrich with no further 
purification. Initially, naproxen purchased from MP Biomedicals was considered, but it did not 
effectively dissolve at our desired concentrations (15.9 μg·mL-1 in H2O at 25°C), which ranged 
as high as 194.0 mg·mL
-1
.
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 Naproxen-sodium—identical to naproxen besides a replacement of 
the carboxyl H
+
 with Na
+—was found to be a suitable substitute (solubility in H2O at 25°C is 
250 mg·mL
-1
).
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 For the main experiment, D2O (Acrōs) was used as the only solvent (as it did 
not produce proton signal). BSA was stored at 2°C, while D2O and naproxen were stored at room 
temperature. Glass scintillation vials were used as containers for test samples. Possessing a 
diameter of about 1 inch, and a uniform, thin bottom, they ensured our samples were within the 
magnet’s cross-sectional and vertical scanning range. All containers were capped and sealed with 
parafilm.  
Samples were prepared directly, without the use of stock solutions. To create samples,    
4 mL of D2O were pipetted into a vial, and appropriate masses of BSA and naproxen-sodium 
were individually weighed out, recorded, and added to the vial. The mixture was capped and 
shaken gently for 1-5 minutes upon addition of each solid until full dissolution was achieved. At 
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this point, it was also confirmed using pH strips (Fisherbrand) that the sample possessed a pH 
greater than BSA’s pI of 5.4, at which point the absence of charge interactions would have 
caused undesired aggregation of BSA.
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 When not being tested, samples vials were stored in a 
drawer at room temperature, as it appeared that exposure to light quickened a process in which 
the naproxen-sodium came out of solution. Such a development was reversible, needing only 
slight warming with the hand and a minute or two of gentle shaking; there was no visible change 
in the samples over the course of the experiment apart from this. Our experiments were likewise 
carried out in the dark, since the NMR-MOUSE was housed in a sealed climate-control chamber 
set to constant temperature (20°C) and humidity (50.0 % relative humidity). These measures 
were taken to account for the possibility that naproxen could be undergoing some 
photodegradative process over time. 
2.3 The NMR-MOUSE 
 The single-sided PM-5 NMR-MOUSE (Magritek, New Zealand) was used for all 
experiments. This MOUSE has an applied field strength B0 of 0.4566 T and a field gradient (G) 
of 23.86 T/m. As indicated by the name PM-5, the instrument is rated to give valuable 
information for any sample within 5 mm of the RF coil in the vertical direction; the RF coil is 
contained within a raised section of the magnet housing and has a sensing area approximately   
1-inch square. One 2–mm plastic spacer was in place between the coil and the sensing surface, 
providing an ultimate effective vertical sensing range of 3 mm. An image of the device in use is 
shown in Fig. 14. Our entire experimental apparatus consisted of the MOUSE, a KEA 
spectrometer, and an operating computer running the program Prospa (all by Magritek). Sample 
vials were placed directly onto this surface during experiments, ensuring that as much of the test 
sample was within the effective range of the magnet as possible. The glass underside of each vial 
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was of suitable thinness and uniformity so as not to complicate this effort. Additional elements of 
the apparatus, such as a lift controlling magnet height and a platform for larger samples, did not 
need to be used or considered given this setup.  
2.4 Acquisition Parameters 
 A large number of user-defined acquisition parameters were required for each 
experiment, with some variation depending upon which test was performed. T1-Saturation 
Recovery and CPMG tests were used to determine T1 and T2, respectively, while the Simulated 
Spin Echo test (SSE-T2) was used for T2-D experiments. This section will discuss our settings for 
these parameters for all the sets of experiments carried out, as well as explain our general 
approach and needs in performing a full iteration of the above protocol; further explanation of 
the meaning of selected parameters important to our decision-making process is provided in 
Appendix D. A table is provided that displays the values input for each set of T2-D (SSE-T2) 
experiments (Table 2); an explanation of our experimental structure is given in the section 
following this one—for now, only cover the steps necessary for collecting T2-D data for any 
given sample will be described. 
T1 and T2 values for a given sample were required due to the exact nature of the mathematics 
used to determine the D. Additional terms not listed in the equation as shown in the introduction 
include T1 and T2 such that these terms are insignificant so long as δ « T2 and Δ « T1. These 
relaxation times therefore needed to be known in advance in order to inform our selection of δ 
and Δ during the SSE-T2 test. As implied by the equation for D, the reference signal S0 (the 
greatest signal) is measured at short δ and Δ. In order to collect sufficient information to 
distinguish multiple diffusion coefficients in the sample, the SSE-T2 test was repeated across a 
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range of δ values, where the largest δ-value increment produces the least signal. The specific 
largest and smallest δ were selected by the user in such a way that the simplified equation for D 
did not differ significantly from the complex version (less than a 10% difference); in addition, 
the smallest δ value was chosen in order to ensure the normalized signal intensity was as close to 
1 as possible, to maximize the range of signal amplitudes acquired in the experiment. δ Values 
for other increments were selected by the computer based off of a log scaling, so that the data 
could be assigned a linear fit in a plot of ln (
𝑆
𝑆0
) vs. 𝛾2𝐺2𝛿2 (∆ +
2
3
𝛿) (again, this should 
produce a slope of –D). In addition, the value of the MOUSE’s field gradient (G) had to be 
entered into Prospa. This was calculated via calibration experiments on plain water, whose D is 
known for a range of concentrations thanks to the work of Holz et al. (2000).
24
 At 20°C, the D 
for water is 2.023×10
-9
 m
2
 s
-1
. 
2.5 Main Experiment—BSA & Naproxen Titration 
Initial experiments with BSA-only and naproxen-only samples indicated a disparity between 
the ideal acquisition parameters for tests of each: in short, BSA required few echoes and many 
scans, while naproxen required many echoes and few scans. BSA had a relatively short T2   
(~0.5-7.0 ms, depending upon the degree of dimerization) and therefore needed only 128 echoes 
with an echotime of 60 μs for its entire signal decay to be visualized, but many scans (at least 
2048) were required before its signal became clearly distinguished above the noise. This meant 
that the length of BSA-only tests was primarily determined by the number of scans. On the other 
hand, naproxen had a relatively long T2 (~80 ms on average) that was best measured with 2048 
echoes, but produced adequate signal in only 512 scans; given the correlation between the 
repetition time between scans and the number of echoes used in an experiment, this implied that 
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the length of naproxen-only experiments was mostly determined by the number of echoes. This 
disparity presented a problem of practicality for T2-D experiments on mixes of BSA and 
naproxen-sodium, as we could not combine many echoes with many scans without our 
experiment lengths growing to on the order of days.  
Three main groups of T2-D experiments were decided upon: a BSA-only set, a naproxen-only 
set, and a mixed set. Each possessed their own, consistent sets of acquisition parameters, with 
BSA-only and naproxen-only samples conforming closely to their ideal settings, while a “middle 
ground” set of acquisition parameters that compromised between the two ideals was used for the 
mixed samples. The parameters for each group as mentioned previously can be found in Table 2. 
Performing experiments on these three sets was consistent with the original premise of using   
T2-D for the purpose of molecular identification: identifiable trends in the effects of mixing BSA 
and naproxen-sodium on their respective T2-D signals on their own and as compared to the 
control groups serve to prove that this method can accurately characterize a given sample. To 
increase the amount of information that could be collected from the experiment, a titration of 
naproxen by BSA across several samples was performed, instead of a single comparison test. 
Crucially, the concentration of protons (and therefore the total amount of signal acquired) was 
held constant at 10 M 
1
H; however, the ratio of BSA:naproxen was modified across separate 
sample so that the initial amount of signal produced by each conformed to a specific ratio. Nine 
samples for this group were prepared and tested, which were referred to by this proton signal 
ratio BSA:naproxen: two blanks (10:0 and 0:10) containing only BSA or only naproxen, and 
seven mixed samples with signal ratios 1:9, 3:7, 4:6, 5:5, 6:4, 7:3, and 9:1. The actual initial 
concentrations of both BSA and naproxen-sodium added to each sample are displayed in     
Table 3, as determined by the masses recorded for each ligand during sample preparation. Five 
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additional samples for the naproxen-only group and three for the BSA-only group were prepared 
(along with the BSA and naproxen blanks used in the titration) that matched the concentrations 
of either molecule for the 1:9, 3:7, 5:5, 7:3, and 9:1 (for Naproxen-only) and 1:9, 5:5, and 9:1 
samples (for BSA-only)—this means that each sample had a corresponding total proton signal of 
1, 3, 5, 7, or 9 M 
1
H for Naproxen-only and 1, 5, or 9 M 
1
H for BSA-only. 
2.6 T2-D Data Processing in Prospa 
Raw data from our experiments provided a measure of proton FID echo signal vs. both the 
change in delay time δ (μs) across each increment and the change in time during each scan (ms). 
Further processing in Prospa was required to convert these data into a two-dimensional 
distribution of T2 and D values, using Inverse Laplace transformations. The detailed mathematics 
of this type of transform are complex, and beyond the scope of this thesis. It is enough to 
understand that it operates by applying trial exponential decay functions to the data presented, 
resulting in a two-dimensional distribution of “goodness of fit” that corresponds to the 
distribution of T2 and D values. 
2.7 UV/Vis Quantification 
A Perkin-Elmer Lambda-35 UV/Vis spectrophotometer was used to confirm BSA and 
naproxen-sodium concentration within each test sample after completion of all relevant tests. 
Samples were diluted 100x when containing BSA only, and 1000x when containing naproxen 
with or without BSA. For our main experiments, which used D2O as a solvent, these dilutions 
were each performed by adding either 10 μL or 1 μL (depending upon the dilution scheme) of 
sample along with 990 μL or 999 μL H2O to an Eppendorf tube. 700 μL of this dilution were 
then transferred to a quartz cuvette from Science Outlet (700 μL was the approximate volume of 
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the main cuvette sample chamber). Pure H2O was used as a reference sample. As stated 
previously, [BSA] was determined at 280 nm (ε = 44,331 M-1cm-1),18 while [naproxen] was 
determined at 331 nm (ε = 1744 M-1cm-1).25 The programs UV Winlab and UV Winlab DPV 
were used to operate the spectrometer and calculate the difference in absorbance between the test 
and reference samples at the appropriate wavelengths, respectively. 
It should be noted that some samples with a high concentration of naproxen (1:9 or naproxen 
blank samples, generally) came out of solution after several days. This precipitation could be 
reversed easily for several hours to days by simply warming the sample briefly in one’s hands. 
There is no indication via UV/Vis or T2-D that some degradative process occurred that induced 
an actual change in molecular structure. Nonetheless, all T2-D and relaxometric experiments 
were carried out as soon as possible after sample preparation. 
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3 Results & Discussion 
3.1 Overview of Whole Series of T2-D Figures 
The full series of our T2-D distribution results for all samples is displayed in Figures    
15-31. Table 3 displays the initial and equilibrium concentrations (in both a chemical and proton 
basis) of BSA, naproxen, and the complex of the two as determined by the recorded masses of 
BSA and naproxen-sodium for each sample during sample preparation. Also listed in Table 3 is 
the expected fraction of 
1
H signal produced by both free BSA and complexed BSA, labelled 
f([B]eq+[BN]eq). Since free BSA and bound BSA are roughly identical in size (66,463 Da for 
BSA versus 66715.24 Da for BSA-naproxen complex), there ought to be little difference in their 
T2-D distribution signals. Furthermore, according to the KD for BSA-naproxen binding   
(3.27×10
-8
 M), the concentrations of naproxen-sodium required to achieve the desired proton 
concentration ratios results in essentially all the BSA being converted to complex (again, see 
Table 3), whereas only a small portion of the naproxen should be bound (in the 9:1 sample, for 
instance, 97.5% of naproxen molecules ought to be unbound).  Once the data were inverted to a 
T2-D distribution, a peak-picking routine found the centers of the peaks. Error estimates for both 
T2 and D were found by creating a contour at 90% of the maximum height of each peak         
(Fig. 32). This error-bounding process, while not statistically rigorous, provides a consistent 
means of analysis from signal to signal. The 90% threshold was selected to reduce the influence 
of “streaks” in the data on our results—samples that did not demonstrate complete signal decay 
within 1024 echoes (most often high-concentration naproxen samples) did not produce a clear 
upper bound to the range of transverse relaxation, resulting in a “streak” in the T2 dimension. 
Streaking could still influence the measurement of a given proton source’s signal fraction, 
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however, since these values had to be calculated based on a manually-selected region for a given 
T2-D distribution. The signal fraction of peaks that exhibited streaking was therefore often 
underestimated (for example, signal 1 from the 0:10 and 1:9 samples).  
3.2 Naproxen-only & BSA-only Controls 
The BSA-only and naproxen-only results distinguish which phenomena observed in the 
titration samples are the direct result of the interaction between BSA and naproxen, and which 
result from the changing concentration of each free component. The “0:10” (all-naproxen) and 
“10:0” (all-BSA) blanks serve as part of both the mixed and non-mixed sample sets.  
The naproxen-only series, for instance, appears to show a major and minor signal. The 
major peak possesses a signal fraction that ranges from 48-87%; however, in higher 
concentrations, this value is underestimated by the signal’s streaking in the positive T2 direction. 
Thus the true signal fraction for each affected major peak in this series of data is likely higher 
than measured. The major peak appeared across a range of T2 and D values respectively of    
~30-130 ms and ~1.0-1.2×10
-10
 m
2
s
-1
. These T2 values do not appear to possess a concentration 
dependence, however, and are associated with large error boundaries (the magnitude of the range 
of T2 values within our 90% maximal peak contours was typically between ~70-100 ms). In 
contrast, a gradual increase in D was observed as the concentration of naproxen decreased     
(Fig. 33). This trend appeared again during the titration experimental series—thus, some possible 
sources of this phenomenon will be discussed later. The minor peak did not appear in every 
sample, but possessed a consistent T2-D distribution when it was encountered: T2 = ~0.3-1.0 ms 
and D = ~9.0-1.1 m
2
s
-1
. One indication that this signal is not merely an artifact of our inversion 
algorithm is that its signal fraction increases as the total proton signal decreases in magnitude 
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([naproxen] decreases), from 0.67% in the “1:9” 9.0 M 1H sample to 21% in the “7:3” 3.0 M 1H 
sample. This suggests that these samples do indeed contain a second proton source. It is possible 
that, within our range of naproxen concentrations, self-association of naproxen molecules occurs, 
resulting in the formation of naproxen aggregates. This is supported by the minor peak’s lower 
T2, and, as is shown later, the increase in naproxen D as [naproxen] decreases, which is observed 
both in the major peak of the naproxen-only series and the naproxen signal of the titration series. 
No trends in T2 or D appear in the BSA-only control series; however, a splitting of signal 
from one peak into two is observed as [BSA] increases. At proton concentrations lower than     
10 M 
1
H only one peak is observed, whereas two are measured in the BSA blank sample          
(10 M 
1
H, or 2.166 mM BSA), a major and minor peak with respective signal fractions of ~63% 
and ~37% (Fig. 23). The major peak has a shorter T2 and smaller D: 2.56 ms and             
1.04×10
-10
 m
2
s
-1
 for T2 and D respectively, in contrast with the minor peak’s 31.90 ms and 
1.47×10
-10
 m
2
s
-1
. This splitting of signal may indicate that our data depicts the increasing 
presence of dimerized-BSA, which is known to form at high concentrations as mentioned 
earlier.
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 Based on the signal fractions of the two peaks, we can estimate the KD for our sample to 
be 9.4×10
-4
 M—since dimerized BSA contains twice as many protons as monomeric BSA, the 
signal fractions indicate that (in a proton basis) the ratio of dimer to monomer is equivalent to 
0.315:0.37. This ratio can then be converted to a molecular basis and used to find the equilibrium 
concentrations of the two forms of BSA given that [BSA]initial = [BSA]eq + 2[BSA2]eq, as 
shown below: 
[BSA]eq =
0.37
0.315
[BSA2]eq ≈ 1.17[BSA2]eq  
1.17[BSA2]eq + 2[BSA2]eq = 3.17[BSA2]eq = [BSA]initial 
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At this point, KD can then be calculated as [BSA]eq
2 [BSA2]eq⁄ . This dissociation constant implies 
that the dimer:monomer signal fraction should change significantly across our samples, with 
monomer comprising approximately 70%, 43%, and 35%  of the total signal for the 1:9, 5:5, and 
9:1 BSA-only samples, respectively. To rule out the possibility of sample contamination (either 
during production, or by naproxen-sodium after using the same BSA source many times to 
prepare samples) repletion of this BSA blank experiment with a second 10:0 sample prepared 
using a different source of BSA gave no change in results. 
3.3 BSA-Naproxen Titration 
Identifying Peaks via Signal Fraction Trends 
Two distinct signal peaks were observed for all samples containing both BSA and 
naproxen-sodium, which are referred to here as Signal 1 and Signal 2. A third peak found in the 
9:1 distribution, contributing < 10% of the total signal, was considered to be an artifact of the 
inversion algorithm (Fig. 22). These final results have been re-expressed with appropriate error 
estimates and on linear axes (Fig. 34). Signal 1 ranged from 20-80 ms and 1.0-1.6×10
-10
 m
2
·s
-1
 
for T2 and D, respectively, while Signal 2 ranged from 0.5-4.0 ms and 0.7-1.2×10
-10
 m
2
·s
-1
 for T2 
and D, respectively. In order to identify the source of each signal, Figure 35 depicts the signal 
fraction of both signals as the concentrations of BSA and naproxen change. This change in 
concentration is represented by the fraction of protons in solution as part of BSA. Signal 1 
decreases and Signal 2 increases as the dominant source of protons shifts from naproxen to BSA. 
This suggests that Signal 1 corresponds to that of free naproxen, while Signal 2 corresponds to 
the overlapping BSA and BSA-naproxen complex signals. Their rates of change correspond to 
slopes of -0.6593 for Signal 1 and 0.6067 for Signal 2—as shown in Figure 35, these values are 
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found using trend-lines that have fixed y-intercepts at 1 and 0, respectively, in order to 
circumvent the underestimation of naproxen’s signal fraction caused by “streaks” in the T2 
dimension at high naproxen concentrations.  
Trends in T2 Relaxation – Possible Evidence of Chemical Exchange 
T2 for both signals changes with changing naproxen and BSA concentrations. Signal 2 
(corresponding to BSA) shows an increase in T2 with increasing [BSA] (Fig. 36). Conversely, 
Signal 1 (the naproxen signal) shows a drop in T2 with increasing [BSA], from a maximum value 
of ~80 ms in the 0:10 sample to ~30 ms in the 5:5 sample. At this point, T2 remains unchanged 
despite further increase in [BSA] (Fig. 36). The point at which this leveling off in T2 occurs 
corresponds to a molecular BSA:naproxen ratio of approximately 1:350. It is possible that both 
this initial drop and eventual plateau in T2 are due to chemical exchange between bound and free 
naproxen. Our method of measurement (collecting echoes) is inherently stroboscopic: we 
measure the signal intensity of an echo once every 60 μs many times (1024) during a single 
acquisition period to get a summed intensity value, making for an acquisition period ~61 ms 
long. If the average length of time naproxen molecules remain bound to a given BSA binding 
site (known as the residence time) is much shorter than this acquisition period, then some 
sizeable portion of the total available pool of free naproxen should experience binding to BSA at 
some point during the acquisition period. In this case, the relaxometric characteristics of 
exchanging naproxen changes over the course of data acquisition; the observed naproxen proton 
signal should no longer describe simply free naproxen, but instead an average of the T2 of free 
naproxen and bound naproxen weighted by the average residence time. As the concentration of 
naproxen decreases relative to BSA, this free naproxen pool decreases and the relative number of 
naproxen molecules able to bind to BSA increases, sharpening this effect and resulting in a 
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concentration-dependent drop in T2. At the point where maximal exchange is occurring (all of 
the naproxen cycles through bound and unbound states during a signal acquisition period), this 
average should then remain constant regardless of further decreases in [naproxen], giving rise to 
a plateau T2 value. 
The degree of exchange occurring in our titration samples can be approximated in the 
following way: The residence time for a single naproxen molecule in a given binding site 
depends upon that site’s KD, such that: 
𝐾𝐷 =
𝑘𝑜𝑓𝑓
𝑘𝑜𝑛
 , 𝑘𝑜𝑓𝑓 = 𝐾𝐷 ∙ 𝑘𝑜𝑛 ;  
1
𝑘𝑜𝑓𝑓
= 𝑟𝑒𝑠𝑖𝑑𝑒𝑛𝑐𝑒 𝑡𝑖𝑚𝑒 ;  𝑘𝑜𝑛 = 4𝜋(𝐷1 + 𝐷2)(𝑟1 + 𝑟2)𝑁𝐴 
where KD is in units of M
-1
, kon in units of M
-1
s
-1
, and koff in units of s
-1
; D1 and D2 refer to the 
self-diffusion coefficients of the two molecules (m
2
s
-1
), r1 and r2 correspond to their radii (m) 
assuming a spherical geometry, and NA is Avogadro’s number. The number of naproxen 
molecules that cycle through a single, specific binding site is found by dividing the acquisition 
period time by the residence time; the percentage of naproxen molecules that exchange during a 
single acquisition period is found by dividing the number that exchange per binding site by the 
ratio of total naproxen molecules to total BSA binding sites available. The relevant values 
describing our 5:5 sample can be used to demonstrate this calculation, with molecule 1 
corresponding to naproxen, and molecule 2 corresponding to BSA. Though it will become clear 
that chemical exchange of naproxen through the BSA binding site should be negligible, these 
results may still be due to exchange if some non-specific binding interactions between naproxen 
and BSA are occurring. For this sample, D1 = ~1.2×10
-10
 m
2
s
-1
, D2 = ~8.6×10
-11
 m
2
s
-1
;                
r1 = 6.41 Å, r2 = 28.8 Å; KD for the BSA binding site was 3.27×10
-8
 M. From these it can be 
calculated using the equations listed above that the residence time for the binding site is  
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5.57×10
3
 ms. Given the acquisition period time of 61 ms, the number of naproxen molecules 
exchanging through each binding site is 0.011. Since there are about 700 naproxen molecules to 
every BSA dimer in solution, maximal exchange ought to be reached when approximately                 
700 naproxen molecules can exchange per corresponding binding site across all dimers per 
acquire period. The theoretical percentage of exchanging naproxen molecules, therefore, should 
be 0.011 700⁄ × 100% ≈  1.4 × 10
−4%. Given this value, it is clear that exchange through the 
naproxen-binding site of BSA is minimal. If it is the case, however, that naproxen at our 
concentration range binds BSA non-specifically (evidence for this is described in Section 3.4), 
naproxen exchange may still be occurring—the implication of some non-specific interaction 
being that it could be described by a very large KD, and the residence time should be much 
shorter. 
 This hypothesis leads us to question whether other forms of exchange could be taking 
place beyond those associated with naproxen-BSA interactions and T2. The same analysis used to 
determine the degree of exchange during the T2 acquisition period may be applied to the 
diffusion acquisition period (which was 2δ + ∆= 2(0.815 ms) + 1.0 ms = 2.63 ms at its 
greatest), which is a much shorter period of time. It is therefore unclear whether non-specific 
naproxen exchange could influence our results in terms of D as well as T2. Additionally, 
chemical exchange could occur between the BSA monomer and dimer forms. At BSA 
concentrations near the KD value for dimerization (9.4×10
-4
 M), there will be a significant change 
in the ratio of monomer to dimer as the concentration of BSA changes. At high and low 
concentrations relative to KD, the dimer will have a large and short “residence time”, 
respectively, pushing the effect of chemical exchange on D and T2 to one of two extreme limits. 
Near KD, however, both dimer and monomer are present in significant quantities, and the effects 
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of chemical exchange will be maximized. Investigating the total effects of BSA dimerization on 
the observed signal will require further study, though it may be complicated by limits on the 
maximum BSA concentration that is still detectable. High-field NMR, as well as other 
spectroscopic techniques, may be best able to resolve this issue. 
Trends in Diffusion 
 The self-diffusion coefficients for BSA and naproxen respond to changes in 
concentration similarly to how they did in the naproxen-only and BSA-only control series. Once 
again, no discernable trend was observed for D of BSA with changing concentration.  Likewise, 
there was an increase in D for naproxen as [naproxen] decreased (Fig. 37), in near identical 
fashion to the results of the naproxen-only control sample; the lines of best fit describing the rate 
of increase in D vs. the fraction composition of BSA both possess strong correlations and similar 
slopes (R
2
 values for the titration and control data fits were 0.828 and 0.9604, respectively, and 
their respective slopes were comparable at 5.39×10
-11
 and 3.0×10
-11
). This trend is unexpected, 
as one would expect naproxen to diffuse more slowly with greater [BSA] on account of the 
greater portion of naproxen bound and therefore diffusing with BSA. Since the trend is observed 
in both the naproxen-only and titration series, it is possible that the phenomenon responsible is 
independent of the presence of BSA. As mentioned before, this could be due to self-association 
of naproxen into aggregates. With less naproxen in solution, fewer naproxen molecules should 
self-associate and therefore diffuse faster on average. Two possible factors involving BSA that 
could explain this trend might also be suitable avenues of further study: changes in the sample’s 
viscosity with changing proportions of BSA and naproxen, and/or changes in charge 
concentration. The former possibility rests on the notion that BSA (with many acidic protons) 
can exchange 
1
H with 
2
D atoms of the D2O solvent, generating small amounts of HOD. Since 
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HOD is less viscous than D2O (1.1248 m·Pa·s for HOD as compared to 1.2467 m·Pa·s for D2O 
at 20°C),
26
 the overall viscosity of the sample will decrease as more BSA is added, resulting in 
faster diffusion (D ∝  
1
𝜂
 according to the Einstein-Stokes equations, where η is viscosity). 
Alternatively, the change in diffusion could be a reflection of the changing charge environment 
within the sample as naproxen is replaced by BSA. At high levels of naproxen (which is weakly 
negatively-charged in comparison to BSA), the consistent spread of charge could slow down 
both BSA and naproxen molecules moving throughout the sample, on account of there being less 
space for these particles to “build momentum” before being repelled back in a different direction. 
In samples with high [BSA] and low [naproxen], however, most of the negative charge would be 
concentrated on the large but sparsely distributed BSA molecules, allowing for particles to move 
more freely.  
 One final oddity to consider is the anomalously low diffusion rates we observed for 
naproxen in general throughout these experiments. Despite being a much smaller molecule than 
BSA, it exhibited a relatively similar D (usually ~1.0-1.5×10
-10
 m
2
s
-1
). One possible explanation 
may be the hydrophobicity of naproxen’s largely aromatic structure restricting its movement 
within our polar solvent D2O. This is unlikely to be a major factor as naproxen anions will repel 
each other when the charge density gets large, however. Alternatively, it could be the case that 
the interactions between the polar solvent and the two solutes (naproxen and BSA) are quite 
different, owing to differences in the molecules’ hydrophobicity and hydrogen-bond-forming 
capacity. This may be explored by looking at the effects of solvent on the measured diffusion 
coefficients. 
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3.4 UV/Vis Concentration Checks 
 Analysis of our samples by UV/Vis yielded limited success in the context of confirming 
the concentrations of BSA and naproxen-sodium in test samples containing both solutes. Results 
consistently put [naproxen] at about 20% below the expected concentration, while [BSA] was 
measured to be far greater in the mixed samples than in the 10 M 
1
H BSA Blank (the [BSA] for 
which was 2.126 mM, in comparison to the target [BSA] of 2.166 mM). Additionally, [BSA] for 
the mixed samples according to UV/Vis measurements decreased as [naproxen] decreased, rather 
than increased as expected. Calculating these concentrations was complicated by  the significant 
absorbance at 280 nm by naproxen, the wavelength used to measure [BSA]—though BSA 
possesses a much stronger extinction coefficient (44,331 M
-1
cm
-1
 vs. 2327.6 M
-1
cm
-1
), the BSA 
absorbance was overpowered by the high naproxen concentration in solution. Based on the 
lower-than-expected [naproxen], and the fact that [BSA] rises and falls in tandem with 
[naproxen] in samples where both molecules are present (in total contradiction of our sample 
preparation scheme), there may be non-specific binding occurring between naproxen and BSA: 
Being a relatively small, mostly hydrophobic molecule, it is quite possible that naproxen 
molecules gather around and coat the surface of the BSA present in solution, altering their 
absorptive capabilities and resulting in an underestimation of [naproxen] that consequently 
throws off our determination of [BSA]. In the future, we could perform a BSA calibration, where 
[BSA] is changed in the presence of a fixed amount of naproxen—this may give some indication 
about non-specific binding or, at the least, the role that naproxen has on changing the extinction 
coefficient for BSA. 
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4 Conclusions 
4.1 The Experiment as a Proof-of-Principle 
 This experiment assessed as a proof-of-principle the efficacy of a low-field, relaxometry-
and-diffusion-based NMR technique for the task of molecular identification. Our initial 
perspective on the interactions of a given protein-ligand pair, which predicted a rather simple 
scenario in which the formation of a protein-ligand complex would be identified as a third proton 
signal of lower T2 and slower D, is not the standard to which our results ought to be held. As was 
discovered during background research and our own experiments, BSA and naproxen are not a 
simple, “ideal” binding pair. BSA dimerization and possible naproxen aggregation create a 
complex equilibrium environment, which our results indicate are likely complicated by rapid 
chemical exchange and non-specific binding, and may even be affected by the viscosity and local 
charge density in the solution. Ultimately our results indicate two things: (1) that the              
two-dimensional aspect of the experiment provided a decided advantage in the identification and 
tracking of the signals detected; (2) that the interactions of our BSA-naproxen binding pair can 
be characterized by this method, with observable trends lending themselves to hypotheses that 
can be tested in the future.  
 The multidimensional nature of our experimental design is critically important to the 
interpretation of our results. Since the majority of this analysis considered trends in T2 and D 
separately, it may not at first be clear why measuring T2 and D together in a combined pulse 
sequence was preferable to monitoring them one at a time—after all, it is much quicker to 
measure them separately. The greatest advantage to the two-dimensional process is that it affords 
the opportunity to instantly match each corresponding T2 and D value for a given proton source 
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together. This greatly facilitates the identification of peaks: naproxen and BSA peaks could be 
distinguished from each other in the mixed titration samples by a single factor, their respective 
contributions to the total amount of “T2-D signal” measured as concentrations of the two 
molecules changed. In contrast, the same matching process with two one-dimensional 
experiments would require a painstaking comparison of separately-determined T2 and D signal 
fractions for each peak. Our results immediately lend themselves to interpretation thanks to the 
two-dimensional approach. 
 Our relaxation-diffusion correlation measurements effectively monitor a multitude of 
characteristic changes in T2 and D for the BSA-naproxen system. The values of T2 and D can 
identify the presence of this protein-ligand at a particular concentration. Our BSA-only 
experimental series suggests that a portion of the BSA in our solutions experience dimerization, 
while trends in the naproxen-only and titration series hint towards the possible self-association of 
naproxen at high concentrations. There is evidence (in both the titration experiments and UV/Vis 
concentration analyses) of non-specific binding of naproxen to BSA. Perhaps the most intriguing 
result of our research is the possible visualization of chemical exchange by our multidimensional 
technique, which may be the first time low-field NMR has been used for this purpose. Overall, 
this experiment provided a wealth of information that opens up several avenues of future study. 
4.2 Continuing & Future Studies 
 This experiment serves as an initial exploration of our protein-ligand system. Having 
completed that task, there are a number of adjustments to the core experimental design that may 
be prudent to test. First, a drawback of our focus upon a constant concentration of protons within 
each sample is the large amount of naproxen required to produce signal comparable to BSA. 
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While the proton source ratios ranged no more than one order of magnitude, naproxen dominated 
the samples in terms of molecular concentration—for instance, the molecular ratio of BSA to 
naproxen in our 1:9 sample was nearly 1:3200. In order to monitor the binding interactions of 
BSA and naproxen such that the fraction of naproxen binding to BSA changes dramatically 
across samples, we may wish to repeat our experiment with a different set of proton source 
ratios, such as 1:100, 1:50, 1:10, 1:2, 1:1, etc. In this way we could observe a greater range of 
binding affinities. 
 While our current research provides several opportunities to understand our              
BSA-naproxen system better, we may seek to perform similar experiments with a different 
ligand pair. A simpler system may lend itself better to characterization by our T2-D technique. 
The association of avidin and biotin, for instance, is many times stronger than that of naproxen 
and BSA, their binding together being almost permanent (KD  ~ 10
-15
 M).
16,17
 Such a pair would 
likely therefore not experience chemical exchange, allowing for us to probe other influences on 
the   T2-D distribution in greater detail. Biotinylated reagents can also be engineered at a range of 
sizes—we considered using a polyethylene glycol chain with “sticky” biotinylated ends as a 
possible ligand for avidin, for example—providing great control over the degree of change in T2 
and D associated with protein-ligand interactions. Other ligands and NMR hardware may be 
engineered to contain other NMR-detectable nuclei (notably, 
19
F), that could provide high 
sensitivity and remove the need for an aprotic solvent. This may make detection in impure, 
aqueous systems viable. 
 Our results allowed for what may be a novel pursuit for techniques involving low-field, 
single-sided NMR devices: the measurement of thermodynamic binding constants such as KD. Of 
particular note is the potential for measuring KD’s associated with the “multimerization” of 
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proteins, as this is no more difficult to accomplish than the calculation of a KD for any other type 
of binding interaction given the appropriate T2-D data. In this way, our technique could 
complement conventional methods for measuring thermodynamic constants such as isothermal 
titration calorimetry (ITC), for which the determination of KD’s of “multimerization” is a 
complex task. Some research in this area has been performed such as that of Lucas et al.
27
 in 
2004. 
 We were surprised by and rather taken with the possibility of monitoring chemical 
exchange of a number of forms with this technique. Further research is required to confirm the 
actual presence of exchange. First, this could be carried out with our T2-D experimental method 
by comparing results across a range of temperatures, which should influence the exchange rate. 
Another option would be to change the echotime used in our experiments, modifying the rate at 
which we acquire signal echoes and thereby controlling the amount of exchange able to take 
place during each acquisition period. Experiments of this nature can be planned out in advance 
based on calculations such as those shown above in order to effectively probe for a specific form 
of exchange, such as that of naproxen binding to BSA or that of BSA monomer-dimer 
interactions. 
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Appendix A – Abbreviations 
NMR – Nuclear Magnetic Resonance 
FID – Free Induction Decay 
RF – Radiofrequency 
CPMG – Carr-Purcell-Meiboom-Gill 
BSA – Bovine Serum Albumin 
UV/Vis – Ultraviolet/Visual (range of electromagnetism) 
DPV – Data Processing Viewer 
MOPS-K – 3-(N-morpholino)propanesulfonic acid 
NP – Naproxen 
ITC – Isothermal Titration Calorimetry 
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Appendix B – Figures 
Fig. 1: Vector Model for Larmor Precession 
 
Initially, the magnetization vector runs parallel to the magnetic field along the z-axis. If the 
magnetization vector is titled away from the z-axis, it executes a precessional motion in which 
the vector sweeps out a cone of constant angle to the magnetic field direction. The direction of 
precession shown is for a nucleus with a positive gyromagnetic ratio and hence a negative 
Larmor frequency. 
Source: Keeler, James. Understanding NMR Spectroscopy, 2
nd
 ed; John Wiley & Sons, 
Chichester, UK, 2010. 
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Fig. 2: Production of Larmor Precession by RF Power 
 
If the magnetic field along the z-axis is replaced quickly by one along x (for example, during a 
𝜋
2
 
pulse), the magnetization will then precess about the x-axis and so move towards the transverse 
plane. 
Source: Keeler, James. Understanding NMR Spectroscopy, 2
nd
 ed; John Wiley & Sons, 
Chichester, UK, 2010. 
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Fig. 3: Pulse-Acquire Pulse Sequence 
 
Here, the horizontal line serves to denote the sequence of events over time, left-to-right. RF 
power from the coil (represented by the gray bar) is applied to the sample in the form of an      
on-resonance (
𝜋
2
) pulse. The resulting FID signal is shown to have a specific amplitude, 
frequency, and decay rate. The dotted line refers to the “dead time” associated with single-sided 
NMR devices (see Fig. 5). 
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Fig. 4: NMR-MOUSE Magnet & RF Coil 
 
Cross-sectional representation of the NMR-MOUSE magnetic elements; the applied field B0 is 
summarized by the black vector and results from the opposite orientations of magnets on either 
side of the apparatus. As depicted by the gradient triangle top-left, this field direction results in a 
gradient in which B0 weakens in the vertical direction above the magnet. The placement of the 
RF coil is shown by the solid-blue concentric rings—just beneath the surface of the apparatus’ 
scanning area. A corresponding blue vector depicts the direction of the RF field B1 used to cause 
rotation of magnetization away from B0. 
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Fig. 5: Hahn Echo Pulse Sequence 
 
This figure represents the sequence of magnetic pulses used to create a Hahn echo,
10
 using the 
same format shown previously in Fig. 3. As discussed in Section 1.2, the initial FID cannot be 
measured with single-sided devices, on account of the “dead time” before measurements can be 
taken due to residual energy in the RF coil. Here, an initial 
𝜋
2
 pulse is followed after a set time by 
a “refocusing” π pulse, creating an “echo” of the original signal an equal length of time later. 
Only signal amplitude can be measured from the echo; no frequency data is accessible. 
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Fig. 6: Refocusing of Individual Magnetic Moments via a 180° Pulse 
 
Shown here are the magnetization vectors of three magnetic moments (red, green, and blue), just 
as Larmor precession about B0 begins immediately following a 90° pulse (left). Each moment 
precesses in the x-y plane; however, field inhomogeneity results in each moment experiencing a 
different field strength, causing each vector to precess at slightly-different frequencies (the 
magnitude of the vectors here denotes field strength experienced—for example, red rotates the 
furthest because its field strength is greatest). Dephasing of the individual spins therefore occurs 
(second from the left). A 180° pulse is applied to rotate these vectors about the x-axis (third from 
the left) some time after the application of the initial excitation pulse. An equal time length later, 
full reconvergence of the magnetization vectors is observed (right) at the original orientation, 
providing an opportunity to measure an “echo” of the FID. 
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Fig. 7: CPMG Pulse Sequence 
 
 
 
The CPMG pulse sequence.
11,12
 As described above, an initial  
𝜋
2
 pulse is followed after a set 
time by a π pulse to create a Hahn echo. This π pulse is then repeated a given number of times, as 
determined by the user. The echoes (represented by the highlighted signal spikes) experience 
signal decay over time, which can be quantified in order to determine transverse relaxation, T2. 
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Fig. 8: Movement of Sample Particles within a Magnetic Field Gradient 
 
 
 
Implication of diffusion within a magnetic field gradient. Because the precession frequency is 
directly proportional to magnetic field strength, the precession frequency for any given proton 
changes as it moves about within the sample. 
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Fig. 9: Effect of Diffusion on Refocusing Pulses 
 
The three arrows depict three individual magnetization vectors as they precess about the z-axis in 
the x-y plane, distinguished from each other by color (red, green, and blue). The magnitude of 
each magnetization vector is dependent upon the corresponding proton’s placement within the 
magnetic field gradient G. The top row represents perfect refocusing in the absence of diffusion 
(see Fig. 6). The bottom includes diffusion within G—dephasing and consequent signal decay 
results (right) from each particle experiencing a different applied magnetic field B0 at the time of 
refocusing (third from the left) with respect to immediately after excitation (left). 
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Fig. 10: The T2-D Pulse Sequence 
 
In similar fashion to earlier figures, this represents the activity of the RF coil during a single    
T2-D scan. To allow for the measurement of signal decay due to diffusion, the first π pulse of an 
iteration of the pulse sequence is split into two 
𝜋
2
 pulses. The first of these 
𝜋
2
 pulses (and second 
pulse in this sequence) rotates the bulk magnetization vector out of the transverse plane, 
“storing” it along the longitudinal axis; thus, for the entire storage delay period Δ, no signal 
decay due to T2 relaxation occurs. T1 relaxation may still occur, but since its effects are 
negligible as long as Δ « T1. Application of the second 
𝜋
2
 pulse of the two (and third pulse overall 
in this sequence) rotates the magnetization back into the x-y plane, facilitating an echo of the 
original FID to be created that can be measured to detect signal decay resulting from diffusion. 
After this, a regular CPMG sequence can be performed to measure T2. The delay time δ describes 
two periods of time: (1) between the initial excitation 
𝜋
2
 pulse and the start of the diffusion-
related sequence, and (2) between the end of the diffusion-related sequence and the first signal 
echo. The effect of T2 is negligible during each delay period δ if δ « T2.  
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Figure 11: Typical T2-D Raw Data 
 
This plot displays the decay in signal intensity as a result of both T2 and D, with T2 relaxation 
causing signal decay over the length of each acquisition period of echoes, and diffusion causing 
signal decay as the delay time δ increases. The resulting values for T2 and D can be calculated 
using the equations provided in Section 1.3. Note the exponential decay in signal along both 
axes.  
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Fig. 12: Changes in T2-D Resulting from Analyte-Ligand Complexation 
 
This figure depicts the theoretical changes in T2-D distribution signals of naproxen and BSA 
(labelled above) as a result of complexation. Assuming the resulting size increase is the only 
difference, the BSA-naproxen complex should produce a third signal that is lower in both T2 and 
D (diffusing more slowly, and relaxing more quickly).   
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Figure 14: BSA & Naproxen-sodium 
 
 
This depicts the chemical structure of naproxen-sodium (top) alongside the crystal structure for 
dimerized BSA (bottom).
19,20
 When forming a crystal, BSA monomers each bind three naproxen 
(shown here); this is likely not the case when in solution, but no other structure for BSA with 
naproxen is available.
21
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Figure 14: The NMR-MOUSE Apparatus Setup 
 
Shown here is our experimental apparatus, including: (a) the PM-5 NMR MOUSE (Magritek), 
(b) test sample, (c) Kea Spectrometer (Magritek), (d) power source. The sample rests directly on 
top of the magnet housing.  
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Figure 15: Naproxen Blank T2-D Distribution 
 
The following series of T2-D distributions display our data from: (1) the BSA-naproxen titration 
series, (2) the BSA-only control series, and (3) the naproxen-only control series. The BSA and 
naproxen blanks (samples 10:0 and 0:10) can be considered to be part of both the titration and 
control experiments.  
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Figure 16: 1:9 BSA:Naproxen T2-D Distribution 
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Figure 17: 3:7 BSA:Naproxen T2-D Distribution 
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Figure 18: 4:6 BSA:Naproxen T2-D Distribution 
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Figure 19: 5:5 BSA:Naproxen T2-D Distribution 
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Figure 20: 6:4 BSA:Naproxen T2-D Distribution 
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Figure 21: 7:3 BSA:Naproxen T2-D Distribution 
 
  
59 
 
Figure 22: 9:1 BSA:Naproxen T2-D Distribution 
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Figure 23: BSA Blank T2-D Distribution 
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Figure 24: 9:1 BSA-only T2-D Distribution 
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Figure 25: 5:5 BSA-only T2-D Distribution 
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Figure 26: 1:9 BSA-only T2-D Distribution 
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Figure 27: 9:1 Naproxen-only T2-D Distribution 
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Figure 28: 7:3 Naproxen-only T2-D Distribution 
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Figure 29: 5:5 Naproxen-only T2-D Distribution 
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Figure 30: 3:7 Naproxen-only T2-D Distribution 
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Figure 31: 1:9 Naproxen-only T2-D Distribution 
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Figure 32: T2-D Distribution Error-Bounding Demonstration 
 
This plot demonstrates the selection of our error-bounds (red) overlaid on top of the 
corresponding T2-D distribution results. The contour is selected by determining first the point of 
greatest intensity for each peak, then finding each point in the peak that corresponds to 90% that 
intensity. 
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Figure 33: Naproxen-only Concentration-Dependence of D 
  
This plot shows the change in D for naproxen with change in concentration for the naproxen-
only series major peak. For consistency with other figures, the x-axis is labelled as the fraction of 
BSA-containing proton sources contributing to the total signal—this is not a literal description, 
as there is no BSA present in any samples of the naproxen-only series. It corresponds directly to 
1 − (
M H of naproxen1
10
⁄ ). An increase in D is observed as the concentration of naproxen 
decreases. 
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Figure 34: Linear Display of Final Results 
 
This plot features the point of greatest intensity for each signal detected in BSA-naproxen 
titration samples on linear axes. Signal 1 is shown as a white circle (the 0:10 naproxen blank 
sample, which only produced one signal, is labelled with a larger white circle in order to tell it 
apart), while Signal 2 is shown as a black circle. The appropriate error bars for each sample have 
been included—large errors in the positive T2 direction for high [naproxen] samples (which are 
shown in Fig. 35 to correspond to Signal 1) are the result of signal “streaking”. Signal 1 trends 
upwards in D and downwards in T2 as BSA is added and naproxen removed. Signal 2 remains 
roughly constant in terms of D, while gradually increasing in terms of T2 with increasing levels 
of BSA (see inset).  
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Figure 35: Signal Components vs. Fractional Signal Composition of BSA 
 
This plot demonstrates the change in signal fraction for the two signals measured during our 
titration experiment as BSA is added and naproxen removed. As shown in Fig. 33, the x-axis 
refers to the percentage of protons in solution whose source is either BSA or the BSA-naproxen 
complex (the signals for which should overlap). Signal 1 (white circles) displays a regular 
decrease in relative intensity as [naproxen] decreases and [BSA] increases, while Signal 2 (black 
circles) displays the opposite. From this we can determine that Signal 1 corresponds to naproxen, 
and Signal 2 corresponds to BSA (either with or without naproxen in a complex). The data for 
the two signals have both been fit with lines that have fixed y-intercepts at either 0.0 or 1.0. The 
fixing counteracts the inaccuracy in the fit brought about by the underestimation of high-
concentration naproxen sample signal fractions thanks to “streaking”. Additionally, Signal 1 and 
Signal 2 for the 10:0 BSA Blank sample (far right) are displayed, though their only possible 
source is BSA; the splitting of BSA signal may indicate the appearance of BSA dimer at higher 
concentration. 
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Figure 36: T2 vs. Fractional Signal Composition of BSA 
 
Naproxen (Signal 1) and BSA+BSA-naproxen complex (Signal 2) T2 values are displayed here 
with changing concentrations of naproxen and BSA. Naproxen T2 drops as [naproxen] decreases 
and [BSA] increases until the 5:5 sample, at which point it holds steady at ~30 ms. The BSA 
signal (see inset) is shown to increase in T2 as [BSA] increases. 
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Figure 37: D vs. Fractional Signal Composition of BSA 
 
This figure displays the diffusion values for naproxen (white circles) and BSA+BSA-naproxen 
complex (black circles) with changing concentration. For comparison with these titration 
samples, the values for the naproxen-only major peak (red squares) are included (see Fig. 33). 
Both naproxen signals show similar trends, increasing in D as [naproxen] decreases. No trend in 
D is observed for BSA or BSA-naproxen complex. 
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Appendix C – Tables 
Table 1: Chemical Properties of BSA and Naproxen-sodium  
 
  
Bovine Serum Albumin 
(BSA) Monomer Naproxen-sodium 
MW (g·mol
-1
) 66463 252.24 
Extinction Coefficient at 
331 nm (M
-1
·cm
-1
) 1136.1 1744 
Extinction Coefficient at 
280 nm (M
-1
·cm
-1
) 44331 2327.6 
# 
1
H per molecule 4617 13 
Solubility in Water 
(mg·mL
-1
) >150 250 
Approximate Geometry Sphere of radius 28.8 Å Ellipsoid with major axis of 6.41 Å 
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Table 2: Acquisition Parameters for Main Experiment 
 
  BSA Only Titration Samples Naproxen-sodium Only 
B1 Frequency (MHz) 19.44 19.44 19.44 
Repetition Time (ms) 500 3040 3040 
90 amplitude (dB) -10 -10 -10 
180 amplitude (dB) -4 -4 -4 
Pulse Length (μs) 4.75 4.75 4.75 
Echotime (μs) 60 60 60 
NrEchoes (#) 128 1024 1024 
Echo shift (μs) 0.0 0.0 0.0 
Gradient (kHz/mm) 1016 1016 1016 
Dest (10
-9
 m
2
·s
-1
) 0.001 0.001 0.001 
tau min (ms) 0.015 0.015 0.015 
tau max (ms) 0.815 0.815 0.815 
DELTA (ms) 1.0 1.0 1.0 
Increments (#) 7 7 7 
Time increment log scale log scale log scale 
Rx Gain (dB) 31 31 31 
RxPhase (°) 230 230 230 
NrPoints (#) 32 32 32 
Dwell time (μs) 1.0 1.0 1.0 
Scans (#) 4096 2048 512 
Flat filter no no no 
Accumulate yes yes yes 
Phase cycle yes yes yes 
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Table 3: Concentrations of BSA & Naproxen-sodium Used 
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Appendix D – Details of Selected Acquisition 
Parameters 
1. Repetition Time (ms): referred to as rep. time; it determines the amount of delay between 
the administration of each scan, in order to allow for RF power to dissipate out of the coil 
and prevent overheating. The rep. time must scale linearly with the number of echoes 
used. Because it is relatively much larger than most other reasons for delay, rep. time is 
thought of as analogous to the length of each scan, and is therefore critical in deciding or 
determining how long an experiment will take.  
 
2. Scans (#): denotes the number of full pulse sequences of the chosen form to be 
administered in the experiment (CPMG) or increment (T1Sat or SSE-T2). More scans 
results in a greater sum of signal amplitude data, and thus clearer, more reliable results; 
this, however, also lengthens experiments. 
 
3. Increments (#): abbreviated as inc. This is required for T2-D (SSE- T2) experiments, 
which record diffusion data across a range of diffusion delay (δ) times. Each experiment 
consisted of a certain number of increments, which each took a certain number of scans, 
each of which took as long as the repetition time to complete. 
 
4. NrEchoes (#): denotes the number of echoes to be collected in the given experiment. 
Proton sources with slower decay times require more echoes in order to visualize the 
entire decay curve (it is ideal to see full signal decay in the last half of the data collection 
window). Since echoes are acquired with even time spacing (see echotime), this number 
can be used to determine the approximate length of each scan. 
 
5. Echotime (μs): denotes the length in time of each echo acquired. When multiplied by the 
number of echoes, this provides the approximate length of each scan. For all our 
experiments, the echotime was constant at 60 μs. 
 
6. T1 Estimation (ms): also known as T1est. In order to determine T1 accurately, an estimate 
value close to the true one had to be provided. This was accomplished by running several 
T1Sat experiments, starting with an initial arbitrary guess T1est value which was then 
replaced with the results of each successive experiment, until these results consistently 
agreed with each other. By convention, the minimum rep. time can be found by 
multiplying T1est by five. 
 
7. -90/-180amp (dB): these two values characterized the power of each magnetic pulse 
administered. For all our experiments they remained constant at -10/-4. 
 
 
8. Pulse length (μs):  abbreviated as τ. It determines for how long each magnetic pulse is 
administered. The optimum value had to be found before each experiment using a 
calibration (Cal) test.  
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Appendix E – Binding Interactions of BSA & 
Naproxen-sodium 
 Naproxen-sodium binds to a single binding site within a given BSA monomer with       
KD = 3.27×10
-8
 M.
21
 Equilibrium concentrations for naproxen, BSA, and the BSA-naproxen 
complex may be calculated using the classic “ICE Diagram” method, as will be shown below. 
This same process can be employed to calculate equilibrium concentrations for monomeric and 
dimeric BSA. The binding of naproxen to BSA may be displayed thus: 
N + B ⇌ BN 
where N is naproxen, B is BSA, and BN is the BSA-naproxen complex. The corresponding ICE 
diagram displays the initial, change in, and equilibrium concentration for each molecule: 
                                                                  N     +     B      ⇌       BN 
Initial N0 B0 0 
Change -x -x +x 
Eq. N0-x B0-x x 
where N0 and B0 are the initial naproxen and BSA concentrations, respectively. By definition,  
KD = 
[N][B]
[BN]
. The equations developed in the ICE diagram for the equilibrium concentrations of 
each molecule can then be plugged into the definition of KD to produce a quadratic equation: 
3.27 × 10−8𝑀 =
(𝑁0 − 𝑥)(𝐵0 − 𝑥)
𝑥
 ; 0 = 𝑥2 − (𝑁0 + 𝐵0 + 3.27 × 10
−8)𝑥 + 𝑁0𝐵0 
The quadratic formula can then be used for any desired initial concentrations of naproxen and 
BSA to find the value of x, from which the equilibrium concentrations of all three molecules can 
be calculated as shown in the ICE diagram. As per the nature of the quadratic formula, two 
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solutions for x ought to be found; however, one of these solutions ought to be larger than the 
amount of B0 available (B0 being the limiting reagent in every case during our experiment). 
Because KD for this interaction is very small, it turns out that essentially all the BSA is converted 
to BSA-naproxen complex. In the 9:1 sample from our titration series, for instance, which 
features an initial concentration of 77.01 mM naproxen and 1.951 mM BSA, the equilibrium 
concentrations for BSA, naproxen, and the BSA-naproxen complex are 8.496×10
-10
 mM,       
75.1 mM, and 1.951 mM (rounded), respectively.  
 
